Author:
ARSLAN Gülnur,ÖNKOL Tijen,ÖZÇELİK Azime Berna
Publisher
Ankara Universitesi Eczacilik Fakultesi Dergisi
Subject
Pharmaceutical Science,Pharmacology
Reference39 articles.
1. Reece, J. B., Urry, L. A., Cain, M. L., Wasserman, S. A., Minorsky, P. V., Jackson, R. B. (2014). Campbell biology, Boston: Pearson, p.1309.
2. Hochegger, H., Takeda, S., Hunt, T. (2008). Cyclin-dependent kinases and cell-cycle transitions: does one fit all?. Nature reviews Molecular cell biology, 9(11), 910-916. [CrossRef]
3. Shapiro, G. I. (2006). Cyclin-dependent kinase pathways as targets for cancer treatment. J Clin Oncol, 24(11), 1770-1783. [CrossRef]
4. DiPippo, A. J., Patel, N. K., Barnett, C. M. (2016). Cyclin‐dependent kinase inhibitors for the treatment of breast cancer: past, present, and future. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 36(6), 652-667. [CrossRef]
5. Pardee, A. B. (1974). A restriction point for control of normal animal cell proliferation. Proceedings of the National Academy of Sciences, 71(4), 1286-1290 [CrossRef]